1 No-Brainer Space Stock to Buy Before Analysts Drive It to $90 A Share
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has drawn significant analyst attention heading into 2026, backed by a growing backlog and improving margins. The Backlog Tells the Story Rocket Lab ended 2025 with a $1.85 billion backlog, up 73% year…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has drawn significant analyst attention heading into 2026, backed by a growing backlog and improving margins.
The Backlog Tells the Story
Rocket Lab ended 2025 with a $1.85 billion backlog, up 73% year over year. That is not speculative demand — it is contracted revenue sitting on the books. The single largest piece is an $816 million Space Development Agency contract to design and manufacture 18 satellites for the Proliferated Warfighter Space Architecture. On top of that, the company just signed a $190 million contract for 20 hypersonic test flights with the Department of War’s MACH-TB 2.0 program — its largest single launch agreement ever. The contracted revenue provides forward visibility into the company’s near-term financial performance.
Margins Are Moving in the Right Direction
This is not a company burning cash with nothing to show for it. Non-GAAP gross margin expanded from 34.0% in Q4 2024 to 44.3% in Q4 2025 — a 10-point improvement in a single year. Full-year 2025 gross profit grew 78.38% year over year, nearly double the 37.96% revenue growth rate, which means the business is scaling efficiently. Q1 2026 guidance calls for revenue of $185M to $200M, representing roughly 57% year-over-year growth at the midpoint. These metrics reflect improving operational efficiency.
Analyst Consensus Leaves Room to Run
At $70.90 per share, Rocket Lab trades well below the consensus analyst price target of $89.88. Of the 15 analysts covering the stock, 10 rate it a buy and 5 rate it a hold — zero sell ratings. The stock also returned 286.43% over the past year, yet it still sits roughly 29% below its 52-week high of $99.58.
The One Risk Worth Naming
The Neutron medium-lift rocket suffered a stage 1 tank test failure, pushing the first launch target to Q4 2026. That is a real delay. But Neutron is upside optionality, not the core thesis. The Electron launch business ran 21 missions in 2025 with a 100% success rate, and the Space Systems segment is generating record revenue independent of Neutron entirely. The $1.85 billion backlog does not require a single Neutron launch to materialize.
Analysts covering the stock cite the $1.85 billion backlog, expanding margins, and Q1 2026 guidance as key factors in their outlook.
Contact [email protected] for any questions or corrections.
I am a long time investor and student of business, and believe finding good companies that can become great investments is the best game on earth. After 20 years of writing and researching the public markets it is clear that individuals have never had more tools and information to take control of their financial lives. From ETFs and $0 commissions to cryptos and prediction markets there has never been a greater democratization of access to investing.
I write to help people understand the investments available to them so they can make the best choice for their portfolio, whether they're starting out or looking for income in retirement.
